27 Oct 2015 - Joel Vega
ESO conference at EMUC15: Issues and updates in personalised approach to prostate cancer management
With new developments in prostate cancer research, clinicians and healthcare professionals have to come up with the most efficient strategies in diagnosing and managing prostate cancer and experts agree that a personalised approach has a key role in providing optimal care.
29 Sep 2015 - Joel Vega
Conflicting views may hamper progress in early PCa detection
The lack of proper implementation of current guidelines in prostate cancer detection and the conflicting views among cancer experts can slow down key advances in the effective and timely detection of prostate cancer which do not only save many lives but also avoid the need for aggressive treatment.
30 Jul 2015 - Joel Vega
Targeted and immunotherapies: Boosting bladder cancer research
Bladder cancer is a urological malignancy that remains a challenge to both clinicians and researchers. However, recent developments indicate that targeted and immunotherapies will increasingly take a front-line role in treating this deadly disease which is considered as the fifth most common cancer in Europe.
10 Jun 2015 - Joel Vega
High hopes for advances in bladder cancer treatment
Cancer experts have high hopes for advances in bladder cancer treatment despite the widespread perception among medical professionals that studies on the deadly disease are fewer compared with other onco-urological malignancies such as prostate cancer.